Skin fibroblasts in vitro radiosensitivity can predict for late complications following AVM radiosurgery

Radiotherapy and Oncology

Volumn 64, Issue 2, 2002, Pages 153-156

  Raaphorst, Gijsbert Peter ^a   Malone, Shawn ^a   Alsbeih, Ghazi ^a   Souhani, Louis ^a   Szumacher, Eva ^a   Girard, Andre ^a  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

Arteriovenous malformation radiosurgery; Late complications; Skin fibroblasts in vitro radiosensitivity

Indexed keywords

ARTERIOVENOUS MALFORMATION; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FIBROBLAST CULTURE; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IRRADIATION; PREDICTION; PRIORITY JOURNAL; RADIOSENSITIVITY; RADIOSURGERY; SKIN BIOPSY; SKIN FIBROBLAST; TISSUE NECROSIS; TISSUE REACTION;

BRAIN; CELL SURVIVAL; CELLS, CULTURED; DNA REPAIR; FIBROBLASTS; HUMANS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; PREDICTIVE VALUE OF TESTS; RADIATION INJURIES; RADIATION TOLERANCE; RADIOSURGERY; SKIN;

EID: 0036669820     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(02)00076-2     Document Type: Article

References (30)

1. Abadir R.M., Hakami N. Ataxia telangiectasia with cancer. An indication for reduced radiotherapy and chemotherapy doses. Br J Radiat. 56:1983;343-345.
2. Alsbeih G., Malone S., Lochrin C., Gray R., Fertil B., Raaphorst G.P. Correlation between normal tissue complications and in-vitro radiosensitivity of skin fibroblasts derived from radiotherapy patients treated for a variety of tumours. Int J Radiat Oncol Biol Phys. 46:(1):2000;143-152.
3. Alsbeih G., Malone S., Raaphorst G.P. Intrinsic radiosensitivity as a predictive assay in radiotherapy: rationale for multifraction approach. Cah Radiobiol. 5:1997;13-16.
4. Brock W.A., Tucker S.L., Geara F.B., et al. Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer. Int J Radiat Oncol Biol Phys. 32:1995;1371-1379.
5. Brown R.C., Ng C.E., Raaphorst G.P. A comparison of high dose rate, low dose rate and fractionation for optimizing differences in radiosensitivities in vitro. Radiat Oncol Invest. 6:1998;209-215.
6. Brown R.C., Raaphorst G.P., Danjoux C.E., Drouin P. Multi-organ fatal chronic complications following radiation treatment for cancer of the cervix: results of fibroblast assay. Gynecol Oncol. 61:1996;116-121.
7. Burnet N.B., Warm R., Peacock J.H. Low dose-rate fibroblast radiosensitivity and the prediction of patient response to radiotherapy. Int J Radiat Biol. 70:1996;289-300.
8. Coffey R., Nichols D., Shaw E. Stereotactic radiosurgical treatment of cerebral arteriovenous malformations. Gamma Unit Radiosurgery Study Group. Mayo Clin Proc. 70:(3):1995;214-222.
9. Colombo F., Pozza F., Chierego G., et al. Linear accelerator radiosurgery for cerebral arteriovenous malformations. An update. Neurosurgery. 34:(1):1994;14-21.
10. Engenhart R., Wowra B., Debus J., et al. The role of high dose single-fraction irradiation in small and large intracranial arteriovenous malformations. Int J Radiat Oncol Biol Phys. 30:(1):1994;521-529.
11. Flickinger J.C., Kondziolka D., Lunsford L.D., Liscak R., Pollock B. Development of a model to predict permanent symptomatic post radiosurgery injury for arteriovenous malformation patients. Int J Radiat Oncol Biol Phys. 45:2000;1143-1148.
12. Flickinger J.C., Kondziolka D., Maitz A.H., et al. Analysis of neurological sequelae from radiosurgery of arteriovenous malformations: how location affects outcome. Int J Radiat Oncol Biol Phys. 40:(2):1998;273-278.
13. Flickinger J.C., Pollick B.E., Kondziolka D., Lunsford L.D. A dose-response analysis of arteriovenous malformation obliteration after radiosurgery. Int J Radiat Oncol Biol Phys. 36:(4):1996;873-879.
14. Flickinger J., Schell M., Larson D. Estimation of complications for linear accelerator radiosurgery with the integrated logistic formula. Int J Radiat Oncol Biol Phys. 19:1990;143-148.
15. Friedman W., Bova F., Mendenhall W. Linear accelerator radiosurgery for arteriovenous malformations: the relationship of size to outcome. J Neurosurg. 82:(2):1995;180-189.
16. Friedman W., Bova F. Linear accelerator radiosurgery for arteriovenous malformations. J Neurosurg. 77:(6):1992;832-841.
17. Geara F.B., Peters L.J., Ang K.K., Wike J.L., Brock W.A. Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys. 27:1993;1173-1179.
18. Geara F.B., Peters L.J., Ang K.K., Wike J.L., Brock W.A. Radiosensitivity measurement of keratinocytes and fibroblasts from radiotherapy patients. Int J Radiat Oncol Biol Phys. 24:1992;287-293.
19. Geara F.B., Peters L.J., Ang K.K., et al. Intrinsic radiosensitivity of normal human fibroblasts and lymphocytes after high- and low-dose-rate irradiation. Cancer Res. 52:1992;6348-6352.
20. Johansen J., Bentzen S.M., Overgaard J., Overgaard M. Evidence for a positive correlation between in vitro radiosensitivity of normal human skin fibroblasts and the occurrence of subcutaneous fibrosis after radiotherapy. Int J Radiat Biol. 66:1994;407-412.
21. Johansen J., Bentzen S.M., Overgaard J., Overgaard M. Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia and skin erythema after radiotherapy. Radiother Oncol. 40:1996;101-109.
22. Karlsson B., Lax I., Soderman M. Factors influencing the risk for complications following gamma knife radiosurgery of cerebral arteriovenous malformations. Radiother Oncol. 43:1997;275-280.
23. Kjellberg R., Hanamura T., Davis J., et al. Bragg-peak proton-beam therapy for arteriovenous malformations of the brain. N Engl J Med. 390:1983;269.
24. Kondziolka D., Lunsford L., Kanal E., et al. Stereotactic magnetic resonance angiography for targeting in arteriovenous malformation radiosurgery. Neurosurgery. 35:(4):1994;585-590.
25. Kondziolka D., Lunsford L., Flickinger J. Gamma knife stereotactic radiosurgery for cerebral vascular malformation. Loeffler J.L., Alexander E. III, Lunsford L., Stereotactic radiosurgery. 1993;136-146 McGraw-Hill, New York.
26. Malone S., Raaphorst G.P., Gray R., Girard A., Alsbeih G. Enhanced in vitro radiosensitivity of skin fibroblast in two patients developing brain necrosis following AVM radiosurgery: a new factor with potential for a predictive assay. Int J Radiat Oncol Biol Phys. 47:2000;185-190.
27. Peacock J., Ashton A., Bliss J., et al. Cellular radiosensitivity and complication risk after curative radiotherapy. Radiother Oncol. 55:2000;173-178.
28. Raaphorst G.P., Malone S., Szanto J., Gray R. Severe normal tissue complication correlates with increased in vitro fibroblast radiosensitivity in radical prostate radiotherapy: a case report. Int J Cancer. 90:(6):2000;336-342.
29. Russell N.S., Grummels A., Hart A.A.M., et al. Low predictive value of intrinsic fibroblast radiosensitivity for fibrosis development following radiotherapy for breast cancer. Int J Radiat Biol. 73:1998;661-670.
30. Woods G.W., Tyrne T.D., Kim T.H. Sensitivity of cultured cells to gamma radiation in a patient exhibiting marked in vivo radiation sensitivity. Cancer. 62:1988;2341-2345.